[
  {
    "ts": null,
    "headline": "Gilead reports final outcomes from trial of bulevirtide for chronic HDV",
    "summary": "The trial is aimed at assessing long-term efficacy as well as safety of the therapy in 150 chronic HDV patients.",
    "url": "https://finnhub.io/api/news?id=d22e24644f1e3eed7196713a804e1cf537e360d8d3be03929e9ec6b6e21c7cc8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746714423,
      "headline": "Gilead reports final outcomes from trial of bulevirtide for chronic HDV",
      "id": 134325376,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "The trial is aimed at assessing long-term efficacy as well as safety of the therapy in 150 chronic HDV patients.",
      "url": "https://finnhub.io/api/news?id=d22e24644f1e3eed7196713a804e1cf537e360d8d3be03929e9ec6b6e21c7cc8"
    }
  },
  {
    "ts": null,
    "headline": "Earth Day Focus for Gilead Sciences - Every Action Has an Impact",
    "summary": "Creating a healthier world for all starts with taking care of the one we all share. As one of America's Greenest Companies, we're always working to ensure our medicines are delivered in ways that...",
    "url": "https://finnhub.io/api/news?id=3a9dbdfd7c7ae87e6857d3ad579557a090ba4ae0ec4f397b6093c0c6696e878d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746693547,
      "headline": "Earth Day Focus for Gilead Sciences - Every Action Has an Impact",
      "id": 134322928,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "Creating a healthier world for all starts with taking care of the one we all share. As one of America's Greenest Companies, we're always working to ensure our medicines are delivered in ways that...",
      "url": "https://finnhub.io/api/news?id=3a9dbdfd7c7ae87e6857d3ad579557a090ba4ae0ec4f397b6093c0c6696e878d"
    }
  },
  {
    "ts": null,
    "headline": "How To Put $100 In Your Retirement Fund Each Month With Gilead Sciences Stock",
    "summary": "Gilead Sciences (NASDAQ:GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in the areas of unmet medical need in the U.S. and internationally. The 52-week range of Gilead Sciences stock price was $62.07 to ...",
    "url": "https://finnhub.io/api/news?id=75542fa5fbf42b97337cf07766a4489d409152bd87a041a39cf6e685e2553a69",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746670764,
      "headline": "How To Put $100 In Your Retirement Fund Each Month With Gilead Sciences Stock",
      "id": 134316972,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences (NASDAQ:GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in the areas of unmet medical need in the U.S. and internationally. The 52-week range of Gilead Sciences stock price was $62.07 to ...",
      "url": "https://finnhub.io/api/news?id=75542fa5fbf42b97337cf07766a4489d409152bd87a041a39cf6e685e2553a69"
    }
  },
  {
    "ts": null,
    "headline": "Hartford Dividend And Growth Fund Q1 2025 Commentary",
    "summary": "Hartford Dividend and Growth Fund (I Share) outperformed the S&P 500 Index for the quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=c6ad2c923616caf4d39a385096c5b5ecc2af0ac9ed4ce53ee7cde74ed7cdc9c2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746662640,
      "headline": "Hartford Dividend And Growth Fund Q1 2025 Commentary",
      "id": 134314408,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2095584352/image_2095584352.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Hartford Dividend and Growth Fund (I Share) outperformed the S&P 500 Index for the quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=c6ad2c923616caf4d39a385096c5b5ecc2af0ac9ed4ce53ee7cde74ed7cdc9c2"
    }
  }
]